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Abstract
Cerebrospinal ﬂuid (CSF) analysis is the most important tool for assessing central nervous system (CNS) disease. An elevated CSF
leukocyte count rarely provides the ﬁnal diagnosis, but is almost always an indicator of inﬂammation within the CNS.
The present study investigated the variety of diseases associated with CSF pleocytosis.
CSF analyses were identiﬁed through the biochemical database used in the capital region of Denmark in the period from 2003 to
2010. In patients>15 years, clinical diagnoses associated with the ﬁnding of a CSF leukocyte count>10106cells/L were obtained
from discharge records and patient ﬁles.
A total of 1058 CSF samples from 1054 patients were included in the analysis. The median age was 50 (interquartile range: 36–67)
and 53% were male. Eighty-one different diagnoses were identiﬁed in 1058 cases with an elevated CSF leukocyte count, besides
unknown causes. Infections were the most common cause of CSF pleocytosis (61.4%) followed by miscellaneous causes (12.7%),
vascular (9.7%), neurodegenerative (7%), neoplastic (5%), and inﬂammatory conditions (4.2%). Only infections presented with
leukocyte counts>10,000106/L. Infections represented 82.6% of all cases with a leukocyte count >100106/L whereas 56.3%
of cases with at leukocyte counts <100106/L were dominated by disease not related to infection.
The present study may serve as a reminder to clinicians of what diseases and disease categories to suspect when patients present
with CSF biochemistry indicating CNS inﬂammation.
Abbreviations: AUC= area under the curve, BM= bacterial meningitis, CNS= central nervous system, CSF= cerebrospinal ﬂuid,
ROC = receiver operating characteristic.
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1cerebrospinal ﬂuid, which bathes its deepest recesses and
washes the very nerve cells and ﬁbers themselves, is in truth a
mirror which reﬂects every change taking place in that
system.[1]
The value of analyzing the cerebrospinal ﬂuid (CSF) was
recognized even before these words were written almost a
hundred years ago, and has not diminished since then despite
major advances in diagnostics. In particular, the presence and
number of leukocytes in the CSF has been a major criterion in the
diagnosis of diseases of the central nervous system (CNS).[2]
CSF analysis is a high-priority analysis upon suspicion of CNS
disease. A variety of biomarkers indicating degenerative
neurological disease are available, these are not speciﬁc and
can merely serve as a guide to the clinical evaluation. Thus,
clinician in the initial evaluation must rely on “basic” CSF
biochemistry. An elevated CSF leukocyte count rarely provides
the ﬁnal diagnosis, but may indicate an inﬂammatory process
within the CNS and is essential in guiding subsequent decision
making and management. In addition to this, the level of CSF
protein, CSF/blood albumin ratio, and glucose provide important
information on indices of blood–brain barrier breakdown and
the presence of glucose consuming cells/organisms.
Recruitment of leukocytes to the CSF is mediated by the release
of cytokines and chemokines that attract leukocytes and open up
the endothelial barrier, allowing leukocyte chemotaxis. The
number of processes, cell types, and molecules identiﬁed as being
involved in cellular recruitment is increasing and occurs in a
broad spectrum of diseases covering infectious, inﬂammatory
(autoimmune), metabolic, and malignant diseases.[3]
Baunbæk Egelund et al. Medicine (2017) 96:18 MedicineInsight into the biochemical proﬁle of the CSF in different
diseases should be useful knowledge to the clinical decision-
making regarding treatment and supplemental diagnostics. To
the best of our knowledge no such overview is available in the
published literature. In this study, we therefore aimed to
document the variety of conditions that may cause or be
associated with CSF indices of neuroinﬂammation.2. Methods and materials
2.1. Design, setting, and population
This retrospective study is based on the collection of all CSF cell
counts and additional biochemistry from 2 hospitals from
2003 to 2010 and from an additional 3 hospitals from 2008 to
2010. All hospitals were located within the Capital Region of
Denmark.2.2. Inclusion criteria
CSF samples with a leukocyte count >10106cells/L from
patients older than 15 years of age were included in the study.2.3. Exclusion criteria
CSF samples with an elevated CSF count due to blood
contamination; resampling in the same patient within 90 days
of the primary sample; samples related to a neurosurgical
procedure; and samples where patient records are missing were
excluded from the study.2.4. Data collection and variables
All CNS analyses in the study period were retrieved from the
biochemistry databases LABKA I and LABKA II (CSC
Scandihealth, Aarhus, Denmark). Data on CSF leukocyte counts
were extracted automatically from the biochemistry databases.
Samples with a CSF leukocyte count<10106 leukocytes/L were
excluded. Three medical doctors (GBE, KLK, and CTB) reviewed
all patient ﬁles for a discharge diagnosis according to the
International Statistical Classiﬁcation of Diseases and Related
Health Problems, 10th Revision from the World Health
Organization. The 3 medical doctors (GBE, KLK, and CTB)
evaluated all cases to ensure that the diagnosis was in agreement
with information from the patient ﬁles and discharge records. All
data were then reviewed and veriﬁed by a fourth medical doctor
(GE). Cases of CNS infections diagnosed with encephalitis or
viral meningitis but with positive bacterial CSF culture and CSF
biochemistry in accordance with the diagnosis were corrected
and vice versa. If a diagnosis related to the ﬁnding of CSF
leukocytosis was not registered, and no cause for this was
available from the patient records we registered the diagnosis as
“unknown.”
CSF cell count was determined automatically. For each CSF
sample proportion of neutrophils (%), protein (g/L), and glucose
(mmol/L) level as well as the patients’ age and sex were recorded.
Data on biochemical, microbiological, and radiological data
were collected manually by the authors.2.5. Diagnosis categories
The diagnoses were a priori divided into 6 groups based on the
proposed pathogenesis of the disease: infectious, inﬂammatory,2neurodegenerative, neoplastic, vascular, andmiscellaneous. Since
infections were the most common cause of CSF leukocytosis, a
subgroup analysis was performed dividing infectious causes into
the following groups: acute bacterial, chronic bacterial, fungal,
and viral CNS infections and inﬂammation secondary to an
infectious focus outside the CNS (extra-CNS).2.6. Statistics
Descriptive data are reported as counts and percentage, and as
medians and range. Information on missing data is provided in
the tables. Predictive associations between CSF leukocyte count
and a diagnosis of bacterial meningitis (BM) were analyzed
using receiver operating characteristics (ROC). Youden J
statistic/index (J=Sensitivity+ (Speciﬁcity  1)) was calculated
in order to select a cut-off for maximizing classiﬁcation
accuracy.[4] Data were analyzed using SAS Enterprse Guide
version 7.1 (SAS Institute A/S, Carey, NC) andwe used SigmaPlot
version 12.5 (Systat Software, San Jose, CA) for plotting the ROC
curve.2.7. Ethics and consent
The study was approved by the Danish Health and Medicines
Authority (record no. 3-3013-135/1/) and by the Danish Data
Protection Agency (record no. 01706 hvh-2012-016). Danish
legislation does not require informed consent for register-based
studies or ethical approval.3. Results
A total of 8878 CSF analyses were reviewed. Of these, 7819 were
excluded; 6248 due to fewer than 10106 leukocytes/L, 697 due
to age<16 years: 451 due to resampling within 90 days, 205 due
to lack of leukocyte count analysis, 94 of samples was related to a
neurosurgical procedure, 67 sampled were duplicates; and 28
with unavailable patient records: 22 due to blood contamination
and 8 due to mislabeling.
A total of 1058 CSF samples from 1054 patients were
included in the analysis. The median age was 50 (interquartile
range: 36–67) and 53% were male. Eighty-one different
diagnoses were related to an elevated CSF leukocyte count,
apart from unknown causes (Table 1). Viral meningitis was the
most prevalent cause (18.6%), followed by BM (16.7%), Lyme
neuroborreliosis (8.5%), demyelinating disease (6.3%), and
stroke (4.9%).3.1. Demographic data and supplemental CSF
biochemistry
Data on patient age, sex, CSF leukocyte differential counts,
protein levels, and glucose levels are presented in Table 2.3.2. Disease categories
The distribution between the 6 disease categories is shown in
Table 3. Infections were the most common cause of CSF
pleocytosis (61.3%) followed by miscellaneous causes (12.7%),
vascular (9.7%), neurodegenerative (7%), neoplastic (5%), and
inﬂammatory causes (4.2%). Only infections presented with CSF
leukocyte counts >10,000106/L and infections were also the
most frequent cause of disease associated with a CSF leukocyte
count>100106/L, representing 82.6%. Among cases with CSF
6Table 1
Causes of cerebrospinal ﬂuid pleocytosis and associated cell counts.
Infectious n Cell count Miscellaneous n Cell count
Bacterial meningitis 177 1707 [30–54,800] Anoxic brain damage 4 36 [15–129]
Brain abscess 4 352 [22–828] Aplastic anemia 1 12
Cryptococcal meningitis 4 93 [19–467] Brain contusion 6 16 [14–46]
Encephalitis 48 117 [12–1580] Chronic alcoholism 3 29 [12–40]
Endocarditis 9 61 [12–285] Convulsions 28 32 [10–269]
Erysipelas 1 14 Drug overdose 3 24 [13–28]
Fungal meningitis 3 682 [14–1947] Encephalopathy (unspec) 2 72 [54–89]
Herpes zoster 1 72 Hepatic encephalopathy 2 17 [16–18]
HIV (primary) 4 47 [13–87] Hydrocephalus 1 17
Infection without focus 5 11 [10–64] Hypoglycemia 2 12 [11–13]
Infectious radiculitis 1 170 Hyponatremia 3 27 [12–31]
Inﬂuenza 1 12 Iatrogenic (bone marrow transplant) 1 22
Lyme neuroborreliosis 90 121 [10–1436] Iatrogenic (epidural anesthesia) 2 258 [63–453]
Necrotizing fasciitis 1 13 Iatrogenic (intravenous immunoglobulin) 1 182
Neurosyphilis 14 23 [10–123] Iatrogenic (metronidazole) 1 10
Peritonitis 1 13 Iatrogenic (myelography) 1 239
PML 1 36 Ketoacidosis 2 101 [13–189]
Pneumonia 22 12 [10–112] Neck trauma
∗
1 6460
Septicemia 39 29 [10–300] Polyneuropathy 2 19 [10–35]
Spinal abscess 5 72 [10–82] Prolapsed disc 4 26 [12–113]
Subdural empyema 1 1480 Spinal stenosis 25 16 [10–74]
Tonsillitis 1 10 Traumatic hemorrhage 6 81 [10–2610]
Toxoplasmosis 2 131 [10–251] Unknown 32 17 [10–4300]
Tuberculous meningitis 11 213 [12–576] Wernicke encephalopathy 1 11
Ventricle shunt infection 7 287 [13–1186]
Viral meningitis 197 177 [10–1744]
Inﬂammatory n Cell count Vascular n Cell count
Acute transversal myelitis 7 65 [24–333] Arterio-venous malformation 1 72
Bell paresis 8 22 [17–60] Benign intracranial hypertension 1 10
Brain vasculitis 7 33 [10–225] Epidural hematoma 1 135
Conus radiculitis 1 116 Sinus thrombosis 1 16
Elsberg syndrome 2 56 [24–88] Stroke 52 58 [10–5650]
HaNDL† 2 51 [35–67] Subarachnoideal hemorrhage 36 198 [10–7090]
Mononeuritis multiplex 1 63 Subdural hemorrhage 10 377 [10–9554]
Neurosarcoidosis 3 27 [10–33] Vascular dementia 1 19
Optic nerve neuritis 2 27 [10–44]
Polyradiculitis 9 55 [11–82]
Reactive serositis 1 62
Syringomyelitis 1 141
Neurodegenerative n Cell count Neoplastic n Cell count
Amyotrophic lateral sclerosis 1 13 Acute lymphoblastic leukemia 2 35 [11–58]
Atypical parkinsonism 3 14 [10–28] Brain metastasis 7 69 [10–261]
Dementia (unspec) 2 10 [10] Brain tumor (malignant) 10 68 [18–1240]
Demyelinating disease 67 19 [10–119] Chronic leukemia 2 21 [15–27]
Parkinson disease 1 17 Disseminated malignant disease 9 20 [10–64]
Lymphoma 19 24 [10–1448]
Paraneoplastic syndrome 4 23 [10–91]
Cell counts in 106 leukocytes/L. Data are presented as median [range].
PML=progressive multifocal leukoencephalopathy.
∗
The high level of inﬂammation, causing suspicion of bacterial meningitis, was suggested to be caused by a column a trauma-based hemorrhage into the cerebrospinal ﬂuid causing secondary inﬂammation.
† Syndrome of transient headache and neurological deﬁcits with cerebrospinal ﬂuid lymphocytosis.
Baunbæk Egelund et al. Medicine (2017) 96:18 www.md-journal.comleukocyte counts <10010 /L infections constituted 43.3% of
the diagnoses.
Eighty-one cases (7.7%) presented with CSF pleocytosis due to
infections with a focus outside the CNS such as pneumonia,
endocarditis, and septicemia. No microorganisms were detected
and the samples assumed to represent sterile inﬂammation
secondary to other infection.
In 32 cases (3%), no diagnosis was established. These cases
were labeled “unknown.”33.3. Infections
Infectious causes of CSF pleocytosis were further divided into the
following groups: acute bacterial, chronic bacterial, fungal, and
viral CNS infections and inﬂammation secondary to an infectious
focus outside the CNS (extra-CNS). Only 2 cases of parasitic
CNS infections were identiﬁed and they were not included in this
context. Data on CSF biochemistry, age, and sex for these groups
are presented in Table 4.
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4Since BM is arguably the most urgently treatable cause of CNS
inﬂammation, we evaluated cut-offs for CSF leukocyte count to
discriminate between BM and other CNS disease. We performed
an ROC analysis estimating the probability of BM versus all
other causes (Fig. 1) and versus other infectious causes only
(Fig. 2).
The ﬁrst ROC curve (Fig. 1) yielded an area under the curve
(AUC) of 0.92. Calculating the Youden J index suggested a
leukocyte count of 414 as cut-off for diagnosing bacterial
infection versus all other causes and it resulted in a sensitivity of
81%, a speciﬁcity of 89%, a positive predictive value off 62%,
and a negative predictive value off 96% (Table 5).
The second ROC curve (Fig. 2) yielded an AUC of 0.90.
Calculating the Youden J index suggested a leukocyte count of
421 as cut-off for diagnosing bacterial infection versus other
infectious causes and it resulted in a sensitivity of 80%, a
speciﬁcity of 86%, a positive predictive value off 71%, and a
negative predictive value off 92% (Table 5).
We further investigated 3 different cut-offs for CSF leukocyte
count: ≥100, ≥500, and ≥1000, to discriminate BM from all
other causes and from other infectious causes, see Table 5. We
found that sensitivity decreased and speciﬁcity increased with
increasing CSF leukocyte count, as expected.4. Discussion
The presented data illustrate the variety of diseases that may be
associated with an inﬂammatory process within the CNS. To our
knowledge, no recent studies have presented data related to the
causes of CNS inﬂammation on such a large number of cases.
Infections presented with the highest CSF leukocyte counts and
were also the most frequent cause of CSF pleocytosis, represent-
ing 61.4% of cases. Among patients presenting with CSF
leukocyte counts below 100106/L, however, the causes were
more heterogeneous and noninfectious causes represented 56.7%
of cases.
Our ﬁnding of a considerable number of patients with sterile
CSF inﬂammation secondary to systemic infections such as
septicemia or pneumonia is not surprising since these infections
may precipitate BM. Thus, these cases may represent a
continuum toward the group of patients with culture negative
meningitis although not treated as such. Among children, it is a
well-described phenomenon that urinary tract infections may
also present with sterile CSF pleocytosis.[5] Also a number of
patients did not receive a diagnosis related to the presence of CSF
inﬂammation. This group labeled “unknown” may represent a
group of patient without CNS inﬂammatory disease albeit with
CSF biochemistry differing from the normal population—thus
normal variation.
Based on the CSF leukocyte count alone, which is often the
most quickly obtainable result, we calculated that CSF leukocyte
counts below 414106/L had a high speciﬁcity (89%) and
negative predictive value (96%) for BM in this population. These
results were largely unaffected when performed against all
included diagnoses compared to the selection of infectious
conditions only. Determining the “optimal cut-off” for diagnosis
BM requires weighting the pros and cons. BM is a serious disease
with mortality up to 30%[6] and failing to make a rapid and
correct diagnosis might have fatal consequences. The cut-off
suggested by Youdens index results in an NPV of 96%. Most
clinicians might ﬁnd this inadequate, as 4% would be left
undiagnosed. Lowering the cut-off to 100 would improve the
NPVwith 2%, but reduce the PPVwith nearly 30%. The reduced
6Table 3
Distribution leukocyte count levels in cerebrospinal ﬂuid according to disease categories.
Cell count, 106 leukocytes/L
<100 (n=570) 100–499 (n=273) 500–999 (n=73) 1000–4999 (n=93) 5000–9999 (n=27) >10,000 (n=22) Total (n=1058)
Infectious 43.3% (247) 78.8% (215) 86.3% (63) 86.0% (80) 85.2% (23) 100% (22) 61.4% (650)
Inﬂammatory 6.8% (39) 1.8% (5) — — — — 4.2% (44)
Vascular 9.6% (55) 9.9% (27) 13.7% (10) 7.5% (7) 14.8% (4) — 9.7% (103)
Miscellaneous 20.4% (116) 5.5% (15) — 3.2% (3) — — 12.7% (134)
Neoplastic 7.2% (41) 3.3% (9) — 3.2% (3) — — 5.0% (53)
Neurodegenerative 12.6 (72) 0.7% (2) — — — — 7.0% (74)
Data are presented as percentage (counts).
Table 4
Cerebrospinal ﬂuid analysis characteristics according to infectious categories.
Acute bacterial
(n=194) Missing
Chronic bacterial
(n=115) Missing
Fungal
(n=7) Missing
Extra-CNS
(n=81) Missing
Viral
(n=251) Missing
Sex, % male 57.2 0 59.1 0 71.4 0 55.6 0 47.0 0
Age, y 62 [16–94] 0 49 [16–87] 0 40 [17–58] 0 70 [22–95] 0 38 [16–91] 0
Cell count, 106 leukocytes/L 1555 [10–54,800] 0 110 [10–1436] 0 177 [19–1947] 0 20 [10–300] 0 160 [10–1744] 0
Neutrophils, % 87 [0–99] 91 3 [0–67] 40 88 [3–94] 4 57 [0–100] 53 4 [0–92] 112
Protein, g/L
∗
3.12 [0.02–29] 67 0.94 [0.25–3.81] 16 1.31 [0.81–3.73] 3 0.51 [0.21–1.85] 43 0.72 [0.24–10.01] 89
Glucose, mmol/L† 1.95 [0–10] 60 3.2 [0.5–32] 14 3.35 [1.6–3.3] 3 4.4 [2.4–10.8] 41 3.3 [0.1–7.4] 75
Data are presented as median [range] unless otherwise indicated.
CNS= central nervous system.
∗
Reference values: 0.15 to 0.50 (g/L).
† Reference values: 2.2 to 3.9 (mmol/L).
Baunbæk Egelund et al. Medicine (2017) 96:18 www.md-journal.comPPV could lead to inappropriate antibiotic use, which in this case
would be of little concern due to the limited number of cases.
Although the high AUC of ≥0.90, the cell count cannot alone
conﬁrm or discharge the diagnosis of BM. As shown by Hasbun
et al,[7] predictive scores deﬁned to safely identify urgently
treatable CNS disease need also to include the clinical situation,
the presentation of the patient and further biochemical results.Figure 1. Probability of bacterial meningitis versus all other diagnoses by
receiver operating curve.
5Our cut-offs determined by Youden (414 and 421  10
leukocytes/L) are in agreement with previous studies in children,
albeit our cut-offswere signiﬁcantly lower, andwereacheda similar
speciﬁcity without including any other patient data.[8,9] The lower
CSF leukocyte threshold is likely due to our adult population.
A number of limitations should be acknowledged due to the
retrospective collection of data and diagnoses obtained fromFigure 2. Probability of bacterial meningitis versus other infectious diagnoses
by receiver operating curve.
Table 5
Probability of bacterial meningitis.
Bacterial meningitis versus all other causes of CNS inﬂammation
Cell count cut off, 106 leukocytes/L
≥100 ≥414
∗
≥500 ≥1000
Sensitivity, % 94 81 76 61
Speciﬁcity, % 64 89 92 97
PPV,† % 36 62 66 80
NPV,‡ % 98 96 95 92
Bacterial meningitis versus all other infectious causes
Cell count cut off, 106 leukocytes/L
≥100 ≥421
∗
≥500 ≥1000
Sensitivity, % 94 80 76 77
Speciﬁcity, % 51 86 90 98
PPV,† % 44 71 75 91
NPV,‡ % 95 92 90 86
CNS= central nervous system.
∗
Suggested by Youden J statistic/index.
† Positive predictive value.
‡ Negative predictive value.
Baunbæk Egelund et al. Medicine (2017) 96:18 Medicinedischarge records. We did, however, attempt to minimize these
weaknesses by reviewing the records twice and drawing other
clinical and diagnostic data into consideration where available. A
recent Danish study including also our population speciﬁcally
evaluated the validity of the diagnosis herpes simplex encephalitis
in the Danish National Patient Registry and found that this
diagnosis could only be conﬁrmed in ∼51% of cases based on
strict inclusion criteria and another ∼8% considered to be
probable cases, meaning more than 40% were incorrectly
diagnosed.[10] The diagnostic confusion primarily involves the
diagnosis of viral meningitis and the continuum toward viral
encephalitis, but also culture negative BM may be difﬁcult to
deﬁne.[6]
Many of the patients presenting with an elevated leukocyte
count would most likely have received initial treatment for a
suspected infection prior to receiving the ﬁnal diagnosis. Thus,
the number of infectious conditions may be underestimated. Also,
it is well known that a few cases of severe CNS infections, that is,
BM may present without CSF inﬂammation but often with
positive microscopy. These patients presenting with <10 (106/
L) CSF leukocytes are not included in the presented data. Even
though likely to be few, we cannot for certain exclude that they
would affect our data.6New diagnostics and improved methodologies could increase
the number of correct diagnoses. Interestingly, we did not ﬁnd
any cases receiving a ﬁnal diagnosis of autoimmune encephalitis,
although 2 cases were suspected as having a postinfectious
autoimmune condition and paramalignant limbic encephalitis,
respectively. These diagnoses were not conﬁrmed. Although
autoimmune brain disease does not necessarily present with
pleocytosis, the lack of cases in our data set could imply that this
disease has received focus only in the most recent years and our
data may include misdiagnosed cases.
Even though this study is not a guideline to diagnostics of CNS
diseases, we believe that our data may serve as a reminder to
clinicians of what diseases and disease categories to suspect when
patients present with CSF biochemistry indicating CNS inﬂam-
mation.Acknowledgment
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